series-a
Stage
2
Investors
About
Envisagenics is an AI-driven RNA splicing therapeutics company that leverages its proprietary SpliceCore® AI platform to discover and develop novel RNA splicing therapeutics for oncology and other diseases. They partner with pharmaceutical companies to accelerate drug discovery.
Explore Envisagenics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.